title: The administration of deferasirox in an iron-overloaded dialysis patient.
authors.forename: Ching-Wei
authors.initials: CW
authors.lastname: Tsai
authors.forename: Feng-Jung
authors.initials: FJ
authors.lastname: Yang
authors.forename: Chun-Chieh
authors.initials: CC
authors.lastname: Huang
authors.forename: Chin-Chi
authors.initials: CC
authors.lastname: Kuo
authors.forename: Yung-Ming
authors.initials: YM
authors.lastname: Chen
mesh_terms: D001565:Benzoates / Q000008:administration & dosage*; D000077588:Deferasirox; D006432:Hemochromatosis / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D007502:Iron Chelating Agents / Q000008:administration & dosage*; D019190:Iron Overload / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*; D014230:Triazoles / Q000008:administration & dosage*
chemical_list: D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox